Shining Forward
Accelerating Market Entry, Creating Products with Value, Attracting Investment
Shining Forward
Accelerating Market Entry, Creating Products with Value, Attracting Investment
Build a medical device that works & sells. We get you there.
Where We Shine
Eliomedica, a medical device innovation firm, bridges the gaps between regulatory, business, and development strategies to ensure seamless commercialization. Our integrated approach empowers startups to:
• Create Products with Value
• Accelerate Market Entry
• Attract Investment
Our Top-notch Projects
- At-home, Point-of-Care, In Vitro Diagnostics
- Medical Robotics
- AI Image Analysis & SaMD
- Remote Patient Monitoring (RPM)
- Vascular Embolization Devices
- Pharmacogenetic Testing (PGx)
- Disinfection & Sterilization Devices
Regulatory Affairs
Research & Development
Go-to-Market Strategy
- Strategy and roadmapping
- Pre-submissions and submissions
- FDA communications
- Design History Files (DHF)
Go-to-Market Strategy
Research & Development
Go-to-Market Strategy
- Market landscape analysis
- Value proposition development
- Validation and sales strategy
- Product-market fit strategy
Research & Development
Research & Development
Research & Development
- Pre-clinical and clinical strategies
- Development roadmapping
- Performance testing strategy
- Systems engineering
We will be Your Advocate
We combine engineering, regulatory, and commercialization expertise to transform innovative medical technologies into market-ready products. By leveraging first-principle thinking and systems engineering principles, we address challenges for novel, medium- to high-risk devices from concept to launch — and beyond.
We are committed to delivering agile solutions, strategic insights, and lasting partnerships. Based in Toronto, we work with clients across North America. Contact us to bring your innovation to market.
- Early stage to VC-backed startups
- Spin-offs from large organizations
- Physician entrepreneurs
- MedTech investment firms
- Hospital innovation hubs
Arash Samimi, PhD
Parth Agarwal, MBA
Parth Agarwal, MBA
Founder & Managing Partner
Market Entry Strategy
Highlights:
Regulatory Advisor, EEE Corp Group
Business Dev, StarFish Medical
Systems Eng, Synaptive Medical
Parth Agarwal, MBA
Parth Agarwal, MBA
Parth Agarwal, MBA
Partner
Sales & Go-to-Market Strategy
Highlights:
Business Dev & Investor, MediPines
Business Dev & investor, Pramptex
Golnaz Moeini, RAC
Parth Agarwal, MBA
Golnaz Moeini, RAC
Sr Consultant
Regulatory Strategy
Highlights:
Founder, MedEdge Regulatory
Director at Arterys, RA at Stryker
Emily Hayhurst
Parth Agarwal, MBA
Golnaz Moeini, RAC
Consultant
Design & Communications Strategy
Highlights:
Human Factors Eng, StarFish Medical
Design Researcher, SleepLabs
T. David Pyron
Francis Jeanson, PhD
Brent Bailey, PhD
Sr Consultant
Product Development Strategy
Highlights:
Program Mgr, StarFish Medical
Director, Major manufacturing
Brent Bailey, PhD
Francis Jeanson, PhD
Brent Bailey, PhD
Sr Consultant
Systems Engineering & Robotics
Highlights:
Systems Designer, StarFish Medical
Systems Designer, Synaptive Medical
Francis Jeanson, PhD
Francis Jeanson, PhD
Francis Jeanson, PhD
Advisor
Health Data & AI Strategy
Highlights:
Head, Ontario Brain Institute
Director, UHN
Golddy Kaur
Francis Jeanson, PhD
Francis Jeanson, PhD
Advisor
Regulatory & Business Strategy
Highlights:
SVP, Profound Medical
Founder, MRS and Wisdom Waves
Through the Eyes of our Clients
Eliomedica has been a trusted partner in shaping Unephra’s regulatory strategy for our in-vitro diagnostic device. Their team provided expert guidance on classification, regulatory pathway, and testing strategy for our at-home IVD and successfully guided us through our FDA pre-submission. We highly recommend Eliomedica to any medical device startup seeking exceptional regulatory support.
Farhad Taghibakhsh, PhD
Founder & CEO, Unephra
---
Eliomedica's expertise in regulatory and pre-clinical strategy was invaluable for our MedTech startup, providing the clarity and direction needed to navigate complex compliance landscapes. Their insights significantly enhanced our value proposition, setting a solid foundation for our product development and market entry.
Dr. Anya McLaren-Barnett, MD
Founder, The Sleep Health Organization
---
ElioMedica has been an invaluable partner for NovaTechs, offering exceptional regulatory consulting with a unique blend of expertise, deep knowledge, and an innovative approach. Their method not only supports startups like ours in navigating complex regulatory landscapes but also empowers us to learn and implement regulatory practices effectively. I genuinely look forward to our meetings with ElioMedica - a rare sentiment for regulatory discussions - because of the passion and insight they bring to the table. Each interaction is an opportunity to grow, and their dedication to fostering understanding makes the process both engaging and educational. I wholeheartedly recommend ElioMedica to anyone seeking a partner who combines technical excellence with a collaborative and inspiring approach.
Mohammad Nasiri, PhD
Founder & CEO, NovaTechs
---
We partnered with Eliomedica to collaboratively lay the foundation for a holistic commercialization strategy. The outcome supports our internal alignment and investor communications. Their first-principles and adaptable approach makes them a valuable partner in our journey towards market fit and growth. We found Eliomedica committed to long-term relationships and look forward to ongoing collaboration with them.
Dr Robert Arntfield, MD
Founder & CEO, Deep Breathe AI
Our Community Partners
